July 25, 2019 M&A, Partnerships PR/Corporate Process Analytical Instr.

908 Devices poised to modernize upstream bioprocess analytics with a grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)

07.25.19 908 Devices, a pioneer of purpose-built analytical devices for chemical and biomolecular analysis, announced it has been awarded a technical project grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). This award will fuel continued development of simple, at-line bioreactor process analytics – a collaboration between 908 Devices, MilliporeSigma, the University of North Carolina at Chapel... Read more

July 24, 2019 Licensing, IP, and Legal Life Science Tools Liq. Handling & Robotics M&A, Partnerships PR/Corporate

QIAGEN reports results for second quarter of 2019; updates full-year 2019 outlook due to decision to restructure China NGS partnership

Venlo, the Netherlands, July 24, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced results of operations for the second quarter of 2019, achieving the outlook set for net sales growth and adjusted earnings per share at constant exchange rates (CER). QIAGEN also announced that it intends to restructure the current format... Read more

July 24, 2019 Lab Top-10 M&A, Partnerships

PerkinElmer and EverlyWell Announce Collaboration to Expand U.S. At-Home Health Test Market

Combines PerkinElmer’s expertise in immunodiagnostic testing and state-of-the-art genomics program with EverlyWell’s consumer health offerings WALTHAM, Massachusetts, and AUSTIN, Texas – July 24, 2019 – Today, PerkinElmer, Inc. and EverlyWell, Inc. announced a new collaboration designed to accelerate innovation in and accessibility of consumer-initiated health testing, by adding PerkinElmer’s CLIA-certified and CAP-accredited lab facilities to... Read more

July 23, 2019 M&A, Partnerships

SAVSU Technologies Partners with United Cargo® to Improve Cold Chain Management and Delivery of Cell and Gene Therapies

evo® Cold Chain Management System and LifeGuard Same Day Service Reduce Risks for High-Value, Temperature-Sensitive Biologic Drugs BOTHELL, Wash., July 23, 2019 /PRNewswire/ — BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of a portfolio of best in class bioproduction tools for cell and gene therapies, today announced that SAVSU Technologies, a leading developer of advanced cold chain... Read more

July 23, 2019 Clinical Research/Diagn. M&A, Partnerships

Uman Diagnostics and Bio-Techne Announce License and Supply Agreement for Neurofilament Light Assay

JULY 23, 2019 MINNEAPOLIS, July 23, 2019 /PRNewswire/ — Uman Diagnostics, now part of Quanterix, and Bio-Techne announced today a strategic License and Supply Agreement for the antibodies used in the quantification of neurofilament light (Nf-L) on the ProteinSimple™-branded Ella™ immunoassay platform. Under the terms of the agreement, Uman Diagnostics will supply Nf-L antibodies to Bio-Techne... Read more

July 22, 2019 Environ, Ag./Food & Bev M&A, Partnerships

Neogen awarded USDA contract

CONTACT: Steve Quinlan, Vice President & CFO, 517/372-9200 LANSING, Mich., July 22, 2019 — Neogen Corporation (NASDAQ: NEOG) announced today that it had again been awarded the contract to supply certain dehydrated culture media to the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS). The FSIS uses Neogen Culture Media to monitor raw and ready-to-eat meat... Read more

July 18, 2019 Lab Top-10 Life Science Tools M&A, Partnerships

Merck KGaA, Darmstadt, Germany and Broad Institute Announce CRISPR License Framework to Encourage Innovation

18 JUL 2019 | DARMSTADT, GERMANY New framework simplifies and accelerates access to CRISPR intellectual property for research Merck KGaA, Darmstadt, Germany, a leading science and technology company, and the Broad Institute of MIT and Harvard today announced an agreement between Broad Institute and the Life Science business of Merck KGaA, Darmstadt, Germany to offer non-exclusive licenses... Read more

July 17, 2019 Life Science Tools M&A, Partnerships

IDT and Washington University join forces to increase access to the latest NGS technologies

Jul 17, 2019 Preferred provider program pools expertise to deliver highest-quality sequencing data, even for challenging projects CORALVILLE, IA (July 17, 2019) – As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies. In line with this mission, the company has launched... Read more

July 16, 2019 Forensics & Security M&A, Partnerships Molecular Spectroscopy

Rigaku Analytical Devices, Inc. and DetectaChem, Inc. Have Completed Testing of Their Integrated Trace and Bulk Explosive Detection Solution in Partnership with the Transportation Security Administration (TSA)

Rigaku and DetectaChem chemical identification technologies are integrated into a single handheld solution to deliver advanced automated trace and bulk explosive detection and chemical analysis capabilities. Wilmington, MA / Stafford, TX (July 16, 2019) – Rigaku Analytical Devices, Inc. a leader in handheld and portable Raman analyzers, together with DetectaChem, Inc., with its innovative advanced automated... Read more

July 16, 2019 Cell Analysis Tools Clinical Research/Diagn. M&A, Partnerships

Abcam Enters Cell Editing Market Through Acquisition of EdiGene’s Knock-out Cell Lines and Lysates Portfolio

Largest off-the-shelf diploid KO library, over 2,800 cell lines Cambridge, UK and Beijing, CN: 16 July, 2019 – Abcam plc, a global innovator in life science reagents and tools, is today pleased to announce the acquisition of the entire live cell line and lysates portfolio of EdiGene Inc, a leading company focused on developing genome editing... Read more